Contraceptives Drugs Devices Market Growth & Forecast [2031]

Segments - Contraceptives Drugs Devices Market by Types (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global contraceptives drugs devices market size is projected to expand at a substantial CAGR during the forecast period. The growth of the market is attributed to the increasing patient awareness huge untapped opportunities, economic development, and continuous improvement of health infrastructure.

Contraceptives Drugs Devices Market Key Takeaways

Contraception is the prevention of pregnancy through the use of drugs, barriers, medical devices, and surgical methods to interfere with ovulation, implantation, and fertilization. These drugs are drugs that inhibit sexually transmitted diseases. The increasing prevalence of sexually transmitted diseases such as gonorrhea, chlamydia, hepatitis B, and HIV worldwide is one of the key factors driving market. Some governments in developed and developing countries are also carrying out advocacy activities and promoting the use of effective contraceptives, especially in rural areas, to control populations and prevent the spread of sexually transmitted diseases. This has led to a significant increase in the demand for easy-to-use, removable, and inexpensive contraceptives.

The contraceptive market has multiple distribution channels, including hospital pharmacies, retail pharmacies, clinics, online channels, community channels, and non-governmental organizations. Contraceptive measures for healthcare professionals and the government’s active support for the distribution of contraceptives through government-subsidized hospitals the market is expected to grow significantly in the next few years.

Market Trends, Drivers, Restraints, and Opportunities

Rising adoption of contraceptive devices for preventing unwanted pregnancy and focus on family planning is expected to boost the market during the forecast period.
Rapid growth of the contraceptive industry owing to free distribution of contraceptive devices in hospitals, villages, and government initiatives is major factors fueling the market.
Increasing awareness among females about health effects on teenage pregnancies and demand for oral pills is anticipated to drive the market during forecast period.
High risk of health effects associated with use of contraceptive devices such as hormonal imbalance and availability of alternative contraceptive methods is projected to restrict the market growth.
Lacks of awareness and social acceptance on the use of contraceptive devices act as major factors that can hamper the market growth during the forecast period.
R&D investment and development in contraceptive products to minimize the health effects after consumption is expected to offer significant opportunities for the market players.

Scope of the Report

The report on the global contraceptives drugs devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Contraceptives Drugs Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Types (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Bayer AG; Pfizer Inc.; Merck & Co. Inc.; Teva Pharmaceuticals Ltd; Agile Therapeutics; Allergan PLC; Ani Pharmaceuticals Inc.,

Market Segment Insights:

The oral contraceptives segment holds major market share

Based on types, the global contraceptives drugs devices market is segregated into oral contraceptives, topical contraceptives, and contraceptive injectable. The oral contraceptives segment is estimated to expand at a high CAGR during forecast period. The oral contraceptive tablets are widely regarded as the most convenient way of contraception. If used within 2-3 days of having risky sexual contact, they prevent implantation within the uterus. Their ease of use makes them an excellent contraceptive in the market. These are widely promoted by global firms over huge regions, and hence easily eaten by huge population of the world. According to the World Bank's 2017 survey report, the global fertility rate in 2017 was 2.43 children per woman, down from 2.45 children per woman the previous year.

Contraceptives Drugs Devices Market By Types

The market in North America is projected to hold a major market share

In terms of regions, the global contraceptives drugs devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to develop rapidly, due to modern healthcare infrastructure, high usage of contraceptive medicine, and growing number of government initiatives aimed at expanding the market. As a result, a large portion of the population is at risk of unintended pregnancy because their partners do not utilize contraception properly and consistently. The public is well-informed about these products, and numerous hospitals have stepped in to help patients who have been harmed by their misuse.

Contraceptives Drugs Devices Market By Regions

Segments

Segments Covered in the Report
The global contraceptives drugs devices market is segmented on the basis of

Types

Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Bayer AG
Pfizer Inc.
Merck & Co. Inc.
Teva Pharmaceuticals Ltd
Agile Therapeutics
Allergan PLC
Ani Pharmaceuticals Inc.

Competitive Landscape

The major players in the contraceptives drugs devices market include Bayer AG, Pfizer Inc., Merck & Co. Inc., Teva Pharmaceuticals Ltd, Agile Therapeutics, Allergan PLC, Ani Pharmaceuticals Inc.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Contraceptives Drugs Devices Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contraceptives Drugs Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Contraceptives Drugs Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Contraceptives Drugs Devices Market - Supply Chain
  4.5. Global Contraceptives Drugs Devices Market Forecast
     4.5.1. Contraceptives Drugs Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Contraceptives Drugs Devices Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Contraceptives Drugs Devices Market Absolute $ Opportunity
5. Global Contraceptives Drugs Devices Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     5.3.1. Oral Contraceptives
     5.3.2. Topical Contraceptives
     5.3.3. Contraceptive Injectable
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Contraceptives Drugs Devices Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Contraceptives Drugs Devices Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
7. North America Contraceptives Drugs Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Contraceptives Drugs Devices Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     7.4.1. Oral Contraceptives
     7.4.2. Topical Contraceptives
     7.4.3. Contraceptive Injectable
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
8. Latin America Contraceptives Drugs Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Contraceptives Drugs Devices Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     8.4.1. Oral Contraceptives
     8.4.2. Topical Contraceptives
     8.4.3. Contraceptive Injectable
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
9. Europe Contraceptives Drugs Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Contraceptives Drugs Devices Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     9.4.1. Oral Contraceptives
     9.4.2. Topical Contraceptives
     9.4.3. Contraceptive Injectable
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Contraceptives Drugs Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Contraceptives Drugs Devices Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     10.4.1. Oral Contraceptives
     10.4.2. Topical Contraceptives
     10.4.3. Contraceptive Injectable
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Contraceptives Drugs Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Contraceptives Drugs Devices Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Contraceptives Drugs Devices Market Size and Volume Forecast by Types
     11.4.1. Oral Contraceptives
     11.4.2. Topical Contraceptives
     11.4.3. Contraceptive Injectable
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Contraceptives Drugs Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Contraceptives Drugs Devices Market: Market Share Analysis
  12.2. Contraceptives Drugs Devices Distributors and Customers
  12.3. Contraceptives Drugs Devices Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Bayer AG
     12.4.2. Pfizer Inc.
     12.4.3. Merck & Co. Inc.
     12.4.4. Teva Pharmaceuticals Ltd
     12.4.5. Agile Therapeutics
     12.4.6. Allergan PLC
     12.4.7. Ani Pharmaceuticals Inc.